Loading institutional data...
Loading institutional data...
Held by 331 of 5,944 reporting institutions (95th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Solve the discounted cash flow backwards, then stress-test the assumptions.
This company doesn't have positive free cash flow, so a reverse DCF can't be run.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.14B 100.0% | $1.05B 100.0% | $1.06B 100.0% | $1.10B 100.0% | $840.4M 100.0% | $800.0M 100.0% | $1.21B 100.0% | $1.53B 100.0% | $1.31B 100.0% | $1.19B 100.0% |
| Cost of Revenue | $655.8M 57.4% | $603.9M 57.6% | $632.5M 59.7% | $675.9M 61.5% | $512.3M 61.0% | $514.5M 64.3% | $801.9M 66.5% | $855.6M 55.8% | $716.0M 54.7% | $791.9M 66.7% |
| Gross Profit | $487.5M 42.6% | $444.8M 42.4% | $426.8M 40.3% | $423.3M 38.5% | $328.1M 39.0% | $285.5M 35.7% | $403.8M 33.5% | $418.5M 27.3% | $385.4M 29.4% | $395.8M 33.3% |
| Research & Development | $13.3M 1.2% | $10.9M 1.0% | $9.5M 0.9% | $10.1M 0.9% | $9.8M 1.2% | $9.4M 1.2% | $20.6M 1.7% | $22.9M 1.5% | $24.5M 1.9% | $28.9M 2.4% |
| Selling, General & Admin | $323.4M 28.3% | $296.3M 28.3% | $284.2M 26.8% | $282.8M 25.7% | $260.3M 31.0% | $230.2M 28.8% | $314.9M 26.1% | $311.6M 20.3% | $298.3M 22.8% | $302.7M 25.5% |
| Total Operating Expenses | $325.9M 28.5% | $302.5M 28.8% | $350.0M 33.0% | $351.1M 31.9% | $262.7M 31.3% | $256.4M 32.0% | $347.2M 28.8% | $332.7M 21.7% | $315.2M 24.1% | $398.3M 33.5% |
| Operating Income | $161.6M 14.1% | $142.3M 13.6% | $76.8M 7.3% | $72.2M 6.6% | $65.4M 7.8% | $29.1M 3.6% | $56.6M 4.7% | $85.8M 5.6% | $70.2M 5.4% | -$2.5M -0.2% |
| Interest Expense | $34.0M 3.0% | $40.9M 3.9% | $45.0M 4.2% | $35.6M 3.2% | $16.2M 1.9% | $16.5M 2.1% | $19.6M 1.6% | $28.5M 1.9% | $50.9M 3.9% | $55.9M 4.7% |
| Interest & Investment Income | $5.8M 0.5% | $6.4M 0.6% | $14.9M 1.4% | $1.7M 0.2% | $2.5M 0.3% | $1.6M 0.2% | $1.4M 0.1% | $1.2M 0.1% | $1.5M 0.1% | $800K 0.1% |
| Other Income (Expense), net | -$8.6M -0.8% | -$13.4M -1.3% | -$9.0M -0.8% | -$10.0M -0.9% | $14.3M 1.7% | -$37.7M -4.7% | -$34.1M -2.8% | -$43.4M -2.8% | -$9.2M -0.7% | -$11.1M -0.9% |
| Pretax Income | $57.6M 5.0% | $94.4M 9.0% | $37.7M 3.6% | $28.3M 2.6% | $66.0M 7.9% | -$23.5M -2.9% | $4.3M 0.4% | $15.1M 1.0% | $546.0M 41.7% | -$68.7M -5.8% |
| Income Tax Expense | $17.1M 1.5% | $21.5M 2.1% | $30.8M 2.9% | $24.4M 2.2% | $8.7M 1.0% | -$2.5M -0.3% | -$3.5M -0.3% | $19.8M 1.3% | $28.1M 2.1% | -$28.6M -2.4% |
| Net Income | $40.5M 3.5% | $72.9M 7.0% | $22.2M 2.1% | $205.1M 18.7% | $177.9M 21.2% | $177.6M 22.2% | $38.3M 3.2% | $19.6M 1.3% | $539.8M 41.2% | -$40.1M -3.4% |
| Per Share | ||||||||||
| EPS (Basic) | $1.92 | $3.48 | $1.06 | $9.86 | $8.64 | $8.64 | $1.86 | $0.94 | $25.28 | $-1.86 |
| EPS (Diluted) | $1.91 | $3.45 | $1.05 | $9.83 | $8.57 | $8.64 | $1.85 | $0.94 | $24.76 | $-1.86 |
| Weighted Avg Shares (Basic) | 21.0M | 21.0M | 20.9M | 20.8M | 20.6M | 20.5M | 20.7M | 20.9M | 21.3M | 21.6M |
| Weighted Avg Shares (Diluted) | 21.2M | 21.1M | 21.0M | 20.9M | 20.8M | 20.5M | 20.8M | 20.9M | 21.8M | 21.6M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
5/7 of the 9 checks — 2 couldn't be scored (see above), so the score is out of the 7 with data.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Needs granular two-year detail (receivables, PP&E, D&A, SG&A) — not fully reported.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor; leverage falling year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
Free-cash-flow coverage unavailable. Last year: $26M dividends + $0 buybacks = $26M returned.
9 consecutive years of dividend increases · 5%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Modest payoff on reinvested capital. Current ROIC on all capital: 2%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $115M covers the $200000 due within a year 573.5× over. Scheduled principal only (excludes interest & revolver draws). As of 2025-12-31 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Coverage is adequate but not comfortable. Effective rate ~5.2% on $655M of debt.
Cash of $115M fully covers short-term debt of $200000.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-09-17
No standout strengths flagged.
Where each multiple sits in its own 14-yr range · 98th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 1.5× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 55.8 | 66.5 | 64.3 | 61.0 | 61.5 | 59.7 | 57.6 | 57.4 |
| Gross Profit | 27.3 | 33.5 | 35.7 | 39.0 | 38.5 | 40.3 | 42.4 | 42.6 |
| R&D | 1.5 | 1.7 | 1.2 | 1.2 | 0.9 | 0.9 | 1.0 | 1.2 |
| SG&A | 20.3 | 26.1 | 28.8 | 31.0 | 25.7 | 26.8 | 28.3 | 28.3 |
| Operating Income | 5.6 | 4.7 | 3.6 | 7.8 | 6.6 | 7.3 | 13.6 | 14.1 |
| Income Tax | 1.3 | -0.3 | -0.3 | 1.0 | 2.2 | 2.9 | 2.1 | 1.5 |
| Net Income | 1.3 | 3.2 | 22.2 | 21.2 | 18.7 | 2.1 | 7.0 | 3.5 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on NPO: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
Ranked against 651 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LTM | $29.49T | — | — | — | — | — | — | — | — | — | 160 |
| CAT | $371.6B | 42.5× | 29.7× | 5.5× | 4.3% | 33.8% | 13.1% | 41.7% | 15.4% | 2.7× | 3,616 |
| GE | $328.8B | 38.5× | — | 7.2× | 18.5% | — | 19.0% | 46.6% | 22.2% | — | 3,077 |
| RTX | $259.8B | 39.0× | 18.5× | 2.9× | 9.7% | — | 7.6% | 10.3% | 10.3% | 0.0× | 3,277 |
| BA | $199.4B | 79.4× | 40.2× | 2.2× | 34.5% | 4.8% | 2.5% | 41.0% | 3.3% | 10.0× | 2,435 |
| DE | $185.4B | 37.1× | — | 4.1× | -11.7% | — | 11.0% | 19.4% | 12.6% | — | 2,491 |
| ABBNY | $177.4B | 47.9× | 31.6× | 5.5× | 9.5% | 34.8% | 11.9% | 28.5% | 20.4% | 0.9× | 48 |
| UNP | $167.6B | 23.6× | 16.1× | 6.8× | 1.1% | — | 29.1% | 38.7% | 14.2% | 2.6× | 2,648 |
| ETN | $158.8B | 39.2× | — | 5.8× | 10.3% | 37.6% | 14.9% | 21.0% | 13.9% | — | 2,398 |
| HON | $131.2B | 28.1× | 16.1× | 3.5× | 7.8% | 36.9% | 12.6% | 34.0% | 9.8% | 3.6× | 2,694 |
| LMT | $123.2B | 25.0× | 16.1× | 1.6× | 5.6% | 10.2% | 6.7% | 74.6% | 17.7% | 2.5× | 2,807 |
| PH | $118.7B | 34.1× | 26.8× | 6.0× | -0.4% | 36.9% | 17.8% | 25.8% | 16.7% | 1.6× | 1,845 |
| ADP | $108.3B | 24.9× | — | 4.9× | 6.7% | 46.4% | 20.1% | 73.2% | 40.1% | — | 2,179 |
| GD | $96.2B | 23.0× | 16.9× | 1.8× | 10.1% | — | 8.0% | 16.4% | 12.5% | 1.3× | 2,123 |
| TT | $94.4B | 32.6× | 23.3× | 4.4× | 7.5% | — | 13.7% | 34.0% | 22.1% | 1.1× | 1,658 |
| VRT | $92.4B | 70.8× | 43.8× | 9.0× | 27.7% | 36.3% | 13.0% | 33.8% | 19.4% | 1.4× | 1,748 |
| PWR | $92.2B | 90.7× | 45.8× | 3.2× | 20.3% | 15.0% | 3.6% | 11.5% | 10.6% | 0.4× | 1,659 |
| JCI | $91.9B | 28.0× | — | 3.9× | 2.8% | 36.4% | 13.9% | 25.5% | 14.4% | — | 1,487 |
| HWM | $90.7B | 60.9× | 39.9× | 11.0× | 11.1% | — | 18.3% | 28.2% | 17.9% | 1.3× | 1,399 |
| CSX | $89.1B | 31.1× | 14.4× | 6.3× | -3.1% | — | 20.5% | 22.0% | 22.0% | — | 1,791 |
| MMM | $87.3B | 27.4× | 16.8× | 3.5× | 1.5% | 39.9% | 13.0% | 69.1% | 18.8% | 2.1× | 2,051 |
| WM | $86.0B | 31.8× | 12.1× | 3.4× | 14.2% | 40.4% | 10.7% | 27.1% | 25.3% | 0.1× | 2,262 |
| UPS | $85.0B | 15.3× | 9.5× | 1.0× | -2.6% | — | 6.3% | 34.3% | 13.8% | 2.2× | 2,025 |
| EMR | $83.0B | 36.5× | — | 4.6× | 3.0% | 52.8% | 12.7% | 11.3% | 6.9% | — | 2,112 |
| CTAS | $79.8B | 45.0× | 28.7× | 7.7× | 7.7% | 50.0% | 17.5% | 38.7% | 25.5% | 0.8× | 1,366 |
| NPO | $6.0B | 150.2× | 24.8× | 5.3× | 9.0% | 42.6% | 3.5% | 2.6% | 1.8% | 2.5× | 331 |
Peers = companies sharing NPO's sector (Industrials) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.